TrialInternational journal of clinical oncology2017

Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.

Yosuke Yasuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.